Aclarion launches trial to quantify how Nociscan data changes treatment plans
PremiumThe FlyAclarion launches trial to quantify how Nociscan data changes treatment plans
1M ago
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans
Premium
Press Releases
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans
1M ago
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
Premium
Press Releases
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
1M ago
Aclarion initiated with a Buy at Ascendiant
PremiumThe FlyAclarion initiated with a Buy at Ascendiant
2M ago
Aclarion announced key milestone with their second payer coverage of Nociscan
Premium
The Fly
Aclarion announced key milestone with their second payer coverage of Nociscan
2M ago
Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
Premium
Press Releases
Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
2M ago
Aclarion, Inc. Secures Funds by Expanding Share Count
PremiumCompany AnnouncementsAclarion, Inc. Secures Funds by Expanding Share Count
5M ago
Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
Premium
Press Releases
Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
5M ago
Aclarion’s Nociscan solution to be utilized in LIFEHAB trial
Premium
The Fly
Aclarion’s Nociscan solution to be utilized in LIFEHAB trial
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100